Latest Moderna News & Updates

See the latest news and media coverage for Moderna. We track all announcements, press releases, and industry mentions in real time, all in one place.

Moderna

Developer of mRNA therapeutics and vaccines

modernatx.com

Headquarters: Cambridge, United States
Founded year: 2010
Company type: Public company
Number of employees: 5,000–6,200
Industry: Pharmaceuticals

Last updated October 29

Latest news about Moderna

In short: Moderna unveiled positive melanoma vaccine data, secured FDA flu shot approval, and reported Q2 results.

Company announcements

October 22 Moderna

Moderna announces positive Phase 3 melanoma results

Intismeran plus pembrolizumab significantly reduces recurrence risk. The trial validates individualized mRNA therapy manufacturing.

August 19 Moderna

Moderna announces positive phase 3 results for melanoma therapy

Intismeran autogene plus pembrolizumab improves outcomes in Stage IIB-IV melanoma versus standard-of-care alone.

August 6 Moderna

Moderna announces FDA approval of seasonal influenza vaccine mFLUSIVA

The vaccine is approved for adults 50 years and older, following unanimous support from the FDA's advisory committee.

July 31 Moderna

Moderna reported Q2 2026 financial results and business updates

CEO Stéphane Bancel, President Stephen Hoge, and CFO Jamey Mock discussed performance, cost discipline, and late-stage pipeline milestones.

Media coverage

October 29 WBAL-TV

New mRNA flu vaccine could help adults 50 and older

Moderna said clinical trials show the new mRNA vaccine to be about 27% more effective than the standard flu shot.

October 26 STAT

Five biotech updates to read after ESMO this weekend

Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according to Moderna CEO Stéphane Bancel.

October 22 Dagens industri

Moderna stock falls after leaked study

The pharmaceutical company Moderna plummeted by nearly 25 percent on Wall Street when an internal study was leaked via social media.

October 20 KTNV Channel 13 News

Moderna | 10/20/26

Moderna’s new mRNA flu vaccine, mFLUSIVA, is approved for adults 50 and older. Dr. Bishoy Rizkalla explains how it works, its potential benefits and impo...

Never miss news about Moderna

Track Moderna and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Moderna competitors & trending companies

Browse news for competitors to Moderna and other trending companies.